[EEG performance spectral mapping during drug therapy in a patient with schizophrenic psychosis].
In a paranoid-hallucinatoric patient with chronic course and acute exacerbation a EEG mapping study during neuroleptic treatment was carried out. The typical changes of the alpha power spectra in schizophrenic psychoses as well the normalization after neuroleptic treatment could be found in the alpha map. The changes were in correlation to the clinical state.
Schellenberg
R
R
Institut für Pathologische Biochemie, Medizinische Akademie Magdeburg,Arbeitsbereich Pathophysiologie.
Schwarz
A
A
Knorr
W
W
Schindler
M
M
D000328:Adult; D000513:Alpha Rhythm; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001143:Arousal / Q000187:drug effects*; D001931:Brain Mapping / Q000295:instrumentation*; D002540:Cerebral Cortex / Q000187:drug effects; D002908:Chronic Disease; D004569:Electroencephalography / Q000187:drug effects* / Q000295:instrumentation; D006801:Humans; D008297:Male; D012563:Schizophrenia, Paranoid / Q000188:drug therapy* / Q000523:psychology; D012815:Signal Processing, Computer-Assisted / Q000295:instrumentation*
D014150:Antipsychotic Agents